Pharmaceutical Deviation Report Template

A pharmaceutical deviation is any departure from an approved instruction, procedure, specification, or established standard during manufacturing, testing, or storage. Deviations can be planned (anticipated and pre-approved, e.g., equipment substitution) or unplanned (unexpected, discovered during or after an operation). All deviations must be documented, investigated, and formally closed per GMP requirements including EU GMP Chapter 5, FDA 21 CFR 211, and ICH Q10.

A planned deviation is a pre-approved, temporary departure from a standard operating procedure or specification — the deviation is known and assessed before it occurs (e.g., using backup equipment while primary is under maintenance). An unplanned deviation is unexpected and discovered during or after the operation, requiring retrospective investigation and root cause analysis. Both require documentation and QA approval.

Critical deviations always require CAPA. Major deviations typically require CAPA unless the investigation clearly shows a one-time, non-systemic event. Minor deviations may require CAPA if they are recurring. CAPA is triggered when the root cause is systemic, when recurrence prevention requires process/SOP changes, or when regulatory compliance is impacted. The decision should be documented with justification in the deviation report.

Industry standard: Critical deviations within 30 days; Major within 60 days; Minor within 90 days. Closure requires completed root cause investigation, implemented corrective actions, and QA approval. Extensions require documented justification and management approval. Overdue or improperly closed deviations are among the most common FDA 483 observations and EU GMP non-conformance findings.

Critical deviation: direct or potential impact on patient safety or product quality that could result in a recall or regulatory action (e.g., sterility failure, wrong active ingredient, contamination event). Major deviation: significant but not immediately life-threatening — potential impact on product quality or regulatory compliance (e.g., temperature excursion, equipment calibration failure). Minor deviation: unlikely to affect product quality or patient safety — primarily a documentation or procedural non-conformance.